Tatva Chintan Pharma Chem share news, announcements and annual reports
NSE: TATVABSE: 543321Chemicals & PetrochemicalsSmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,614.80.
30 Oct: open ₹1,624.90, high ₹1,659.00, low ₹1,582.10
- Under NSE's long-term additional surveillance, stage I, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,845 Cr999th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 61.12
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.72
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.12%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 74,35445.2% delivered
Tatva Chintan Pharma Chem share news and announcements
329 announcements, routine notices left out, newest first. Page 5 of 7.
May 2023
5 May · Business
5 May · Management
5 May · Dividend
5 May · Results
Apr 2023
28 Apr · Analysts
Mar 2023
4 Mar · Analysts
Feb 2023
25 Feb · Analysts
13 Feb · Analysts
1 Feb · Business
Jan 2023
24 Jan · Business
24 Jan · Results
24 Jan · Board meeting
13 Jan · Analysts
13 Jan · Board meeting
Dec 2022
14 Dec · Analysts
Nov 2022
24 Nov · Analysts
16 Nov · Related Party Transaction
14 Nov · Analysts
10 Nov · Business
10 Nov · General updates
4 Nov · Business
Oct 2022
31 Oct · Analysts
Sep 2022
29 Sep · Analysts
27 Sep · Analysts
22 Sep · Meeting
22 Sep · Meeting
Aug 2022
25 Aug · General updates
25 Aug · General updates
24 Aug · Analysts
23 Aug · Corporate action
23 Aug · Meeting
6 Aug · Business
6 Aug · General updates
Jul 2022
28 Jul · Analysts
25 Jul · Business
19 Jul · Analysts
15 Jul · Analysts
8 Jul · Legal